Print
|
Close
A Phase 1b/2 Study of BGB-11417in Monotherapy and in Various Combinations With Dexamethasone and Carfilzomib in Multiple Myeloma
Active:
Yes
Cancer Type:
Multiple Myeloma
NCT ID:
NCT04973605
Trial Phases:
Phase I
Phase II
Protocol IDs:
BGB-11417-105 (primary)
NCI-2022-07236
2021-003614-39
U1111-1277-5444
Eligibility:
18 Years and older, Male and Female
Study Type:
Treatment
Study Sponsor:
BeiGene
NCI Full Details:
http://clinicaltrials.gov/show/NCT04973605
Summary
Study consists of two parts, a part 1 dose escalation and a part 2 cohort expansion in
combination with dexamethasone and carfilzomib intravenously across two cohorts with a
monotherapy component as well.
Treatment Sites in Georgia
Winship Cancer Institute of Emory University
1365 Clifton Road NE
Building C
Atlanta, GA 30322
404-778-5180
winshipcancer.emory.edu
**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts...
Click here to learn more about clinical trials
.